Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: J Surg Oncol. 2017 May 25;116(4):482–491. doi: 10.1002/jso.24690

TABLE 1.

Contributing factors for patient declination of postoperative radiotherapy in stage I endometrioid endometrial cancer (N = 10 613)

Characteristic Declined RT Received RT Adjusted-ORa (95%CI) P-value
Number (%) 323 (3.0%) 10 290 (97.0%)
Age (y) 70.8 (±11.5) 65.8 (±10.5)
 <60 61 (2.1%) 2798 (97.9%) 1
 ≥60 262 (3.4%) 7492 (96.6%) 1.52 (1.13-2.04) 0.005
Ethnicity
 White 273 (3.2%) 8383 (96.8%) 1.53 (1.12-2.10) 0.01
 Non-White 50 (2.6%) 1907 (97.4%) 1
Marital status
 Single 42 (3.1%) 1331 (96.9%) 1.37 (0.95-1.96) 0.09
 Married 132 (2.4%) 5397 (97.6%) 1
 Others 149 (4.0%) 3562 (96.0%) 1.65 (1.30-2.11) <0.001
Registry area
 West 231 (4.6%) 4744 (95.4%) 2.13 (1.59-2.86) <0.001
 Central 60 (2.4%) 2453 (97.6%) 1
 East 32 (1.0%) 3093 (99.0%) 0.40 (0.26-0.63) <0.001
Year at diagnosis
 Before 2000 79 (2.7%) 2794 (97.3%) 1
 2000 and after 277 (3.2%) 7496 (96.8%) 1.40 (1.04-1.88) 0.03
Grade
 1-2 175 (3.0%) 5068 (97.0%) 1
 3 148 (3.1%) 4682 (96.9%) 1.12 (0.84-1.49) 0.43
Stage
 IA 76 (2.7%) 2727 (97.3%) 1
 IB 247 (3.2%) 7563 (96.8%) 1.10 (0.78-1.53) 0.59
Tumor size (cm)
 <2.0 19 (2.6%) 713 (97.4%) 1
 ≥2.0 182 (3.1%) 5604 (96.9%) 1.13 (0.69-1.83) 0.63
 Unknown 122 (3.0%) 3973 (97.0%) 1.20 (0.73-1.96) 0.48
Surgery type
 Simple hyst 273 (3.1%) 8610 (96.9%) 1
 Others 50 (2.9%) 1680 (97.1%) 0.98 (0.70-1.37) 0.91
Pelvic lymphadenectomy
 Performed 224 (3.0%) 7134 (97.0%) 1
 Not performed 96 (3.2%) 2895 (96.8%) 0.95 (0.73-1.24) 0.69
 Unknown 3 (1.1%) 261 (98.9%) 0.34 (0.10-1.20) 0.08

hyst, hysterectomy; OR, odds ratio; CI, confidence interval; and RT, radiotherapy. Number (%) per row or mean (±SD) is shown. A binary logistic regression model for multivariable analysis. All listed covariates were entered in the final model. Significant P-values are emboldened. Grade 3 cases included undifferentiated endometrioid type.

a

OR for patient declination for postoperative radiotherapy compared to postoperative radiotherapy.